Neurocutaneous melanosis associated with autoimmune diabetes mellitus.
Joseph
Kevin R
KR
Child Neurology Section, Madigan Army Medical Center, Tacoma, WA, USA. krjoseph1@hotmail.com
Difazio
Marc P
MP
Hartman
Kip R
KR
Ney
John P
JP
D000927:Anticonvulsants; D000970:Antineoplastic Agents; D001323:Autoantibodies / Q000276:immunology; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D001932:Brain Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D018450:Disease Progression; D017809:Fatal Outcome; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D008548:Melanosis / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D008577:Meningeal Neoplasms / Q000473:pathology; D008578:Meninges / Q000473:pathology; D020752:Neurocutaneous Syndromes / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D009508:Nevus, Pigmented / Q000209:etiology; D011878:Radiotherapy; D012640:Seizures / Q000209:etiology; D017211:Treatment Failure
D000927:Anticonvulsants; D000970:Antineoplastic Agents; D001323:Autoantibodies; D005968:Glutamate Decarboxylase